Global Chronic Plaque Psoriasis Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Chronic Plaque Psoriasis Therapeutics
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Chronic Plaque Psoriasis Therapeutics by Type
- 1.3.1 Overview: Global Chronic Plaque Psoriasis Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Chronic Plaque Psoriasis Therapeutics Consumption Value Market Share by Type in 2023
- 1.3.3 Clinical
- 1.3.4 Non-Clinical
- 1.3.5 Inactive
- 1.4 Global Chronic Plaque Psoriasis Therapeutics Market by Application
- 1.4.1 Overview: Global Chronic Plaque Psoriasis Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospitals
- 1.4.3 Ambulatory Surgical Centers
- 1.4.4 Others
- 1.5 Global Chronic Plaque Psoriasis Therapeutics Market Size & Forecast
- 1.6 Global Chronic Plaque Psoriasis Therapeutics Market Size and Forecast by Region
- 1.6.1 Global Chronic Plaque Psoriasis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Chronic Plaque Psoriasis Therapeutics Market Size by Region, (2019-2030)
- 1.6.3 North America Chronic Plaque Psoriasis Therapeutics Market Size and Prospect (2019-2030)
- 1.6.4 Europe Chronic Plaque Psoriasis Therapeutics Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size and Prospect (2019-2030)
- 1.6.6 South America Chronic Plaque Psoriasis Therapeutics Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Chronic Plaque Psoriasis Therapeutics Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Abbvie
- 2.1.1 Abbvie Details
- 2.1.2 Abbvie Major Business
- 2.1.3 Abbvie Chronic Plaque Psoriasis Therapeutics Product and Solutions
- 2.1.4 Abbvie Chronic Plaque Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Abbvie Recent Developments and Future Plans
- 2.2 Novartis International
- 2.2.1 Novartis International Details
- 2.2.2 Novartis International Major Business
- 2.2.3 Novartis International Chronic Plaque Psoriasis Therapeutics Product and Solutions
- 2.2.4 Novartis International Chronic Plaque Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Novartis International Recent Developments and Future Plans
- 2.3 Pfizer
- 2.3.1 Pfizer Details
- 2.3.2 Pfizer Major Business
- 2.3.3 Pfizer Chronic Plaque Psoriasis Therapeutics Product and Solutions
- 2.3.4 Pfizer Chronic Plaque Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Pfizer Recent Developments and Future Plans
- 2.4 Merck
- 2.4.1 Merck Details
- 2.4.2 Merck Major Business
- 2.4.3 Merck Chronic Plaque Psoriasis Therapeutics Product and Solutions
- 2.4.4 Merck Chronic Plaque Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Merck Recent Developments and Future Plans
- 2.5 Astelllas Pharma
- 2.5.1 Astelllas Pharma Details
- 2.5.2 Astelllas Pharma Major Business
- 2.5.3 Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Product and Solutions
- 2.5.4 Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Astelllas Pharma Recent Developments and Future Plans
- 2.6 GlaxoSmithKline
- 2.6.1 GlaxoSmithKline Details
- 2.6.2 GlaxoSmithKline Major Business
- 2.6.3 GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Product and Solutions
- 2.6.4 GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 GlaxoSmithKline Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Chronic Plaque Psoriasis Therapeutics Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Chronic Plaque Psoriasis Therapeutics by Company Revenue
- 3.2.2 Top 3 Chronic Plaque Psoriasis Therapeutics Players Market Share in 2023
- 3.2.3 Top 6 Chronic Plaque Psoriasis Therapeutics Players Market Share in 2023
- 3.3 Chronic Plaque Psoriasis Therapeutics Market: Overall Company Footprint Analysis
- 3.3.1 Chronic Plaque Psoriasis Therapeutics Market: Region Footprint
- 3.3.2 Chronic Plaque Psoriasis Therapeutics Market: Company Product Type Footprint
- 3.3.3 Chronic Plaque Psoriasis Therapeutics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Chronic Plaque Psoriasis Therapeutics Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Chronic Plaque Psoriasis Therapeutics Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Chronic Plaque Psoriasis Therapeutics Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Chronic Plaque Psoriasis Therapeutics Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Chronic Plaque Psoriasis Therapeutics Consumption Value by Type (2019-2030)
- 6.2 North America Chronic Plaque Psoriasis Therapeutics Consumption Value by Application (2019-2030)
- 6.3 North America Chronic Plaque Psoriasis Therapeutics Market Size by Country
- 6.3.1 North America Chronic Plaque Psoriasis Therapeutics Consumption Value by Country (2019-2030)
- 6.3.2 United States Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 6.3.3 Canada Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Chronic Plaque Psoriasis Therapeutics Consumption Value by Type (2019-2030)
- 7.2 Europe Chronic Plaque Psoriasis Therapeutics Consumption Value by Application (2019-2030)
- 7.3 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country
- 7.3.1 Europe Chronic Plaque Psoriasis Therapeutics Consumption Value by Country (2019-2030)
- 7.3.2 Germany Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 7.3.3 France Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 7.3.5 Russia Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 7.3.6 Italy Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region
- 8.3.1 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Consumption Value by Region (2019-2030)
- 8.3.2 China Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 8.3.3 Japan Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 8.3.5 India Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 8.3.7 Australia Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Chronic Plaque Psoriasis Therapeutics Consumption Value by Type (2019-2030)
- 9.2 South America Chronic Plaque Psoriasis Therapeutics Consumption Value by Application (2019-2030)
- 9.3 South America Chronic Plaque Psoriasis Therapeutics Market Size by Country
- 9.3.1 South America Chronic Plaque Psoriasis Therapeutics Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country
- 10.3.1 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
- 10.3.4 UAE Chronic Plaque Psoriasis Therapeutics Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Chronic Plaque Psoriasis Therapeutics Market Drivers
- 11.2 Chronic Plaque Psoriasis Therapeutics Market Restraints
- 11.3 Chronic Plaque Psoriasis Therapeutics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Chronic Plaque Psoriasis Therapeutics Industry Chain
- 12.2 Chronic Plaque Psoriasis Therapeutics Upstream Analysis
- 12.3 Chronic Plaque Psoriasis Therapeutics Midstream Analysis
- 12.4 Chronic Plaque Psoriasis Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Chronic Plaque Psoriasis Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type of psoriasis. This disease condition is associated with several risk factors such as infection, psychological stress and others. Diagnosis of chronic plaque psoriasis is based on clinical appearance, is the case is severe then biopsy is recommended by the healthcare professionals in order to distinguish it from other conditions such as seborrheic dermatitis, ichen simplex chronicus and others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Chronic Plaque Psoriasis Therapeutics industry chain, the market status of Hospitals (Clinical, Non-Clinical), Ambulatory Surgical Centers (Clinical, Non-Clinical), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Chronic Plaque Psoriasis Therapeutics.
Regionally, the report analyzes the Chronic Plaque Psoriasis Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Chronic Plaque Psoriasis Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Chronic Plaque Psoriasis Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Chronic Plaque Psoriasis Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Clinical, Non-Clinical).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Chronic Plaque Psoriasis Therapeutics market.
Regional Analysis: The report involves examining the Chronic Plaque Psoriasis Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Chronic Plaque Psoriasis Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Chronic Plaque Psoriasis Therapeutics:
Company Analysis: Report covers individual Chronic Plaque Psoriasis Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Chronic Plaque Psoriasis Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Centers).
Technology Analysis: Report covers specific technologies relevant to Chronic Plaque Psoriasis Therapeutics. It assesses the current state, advancements, and potential future developments in Chronic Plaque Psoriasis Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Chronic Plaque Psoriasis Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Chronic Plaque Psoriasis Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Clinical
Non-Clinical
Inactive
Market segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Market segment by players, this report covers
Abbvie
Novartis International
Pfizer
Merck
Astelllas Pharma
GlaxoSmithKline
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chronic Plaque Psoriasis Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chronic Plaque Psoriasis Therapeutics, with revenue, gross margin and global market share of Chronic Plaque Psoriasis Therapeutics from 2019 to 2024.
Chapter 3, the Chronic Plaque Psoriasis Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Chronic Plaque Psoriasis Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Plaque Psoriasis Therapeutics.
Chapter 13, to describe Chronic Plaque Psoriasis Therapeutics research findings and conclusion.